EastPharma Ltd Reports Audited Consolidated Earnings Results for the Full Year Ended December 31, 2011
EastPharma Ltd. reported audited consolidated earnings results for the full year ended December 31, 2011. For the quarter, revenue was $242,263,513 against $253,815,680 a year ago. Loss before tax was $16,531,771 against $2,873,867 a year ago. Net loss for the year attributable to equity holders of the parent was $18,059,267 or $0.28 per basic and diluted share against $2,446,028 or $0.02 per basic and diluted share a year ago. Net cash provided by operating activities was $9,574,149 against $5,859,301 a year ago. Purchases of property, plant and equipment was $23,122,201 against $17,615,378 a year ago.